Département Oncologie Gastro-entérologie CHRU de Poitiers La Miletrie

Poitiers 86000

0 studies enrolling now · 1 studies all time

What they study most

HER2-amplified Biliary Tract Cancers

Studies at this site

• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers — Completed